Whitehawk Therapeutics, Inc.
For the period ended Dec 31, 2025. Filed Mar 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 12, 2026
WHWK$3.08-4.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of December 31, 2025 and 2024
Balance Sheets
(in thousands, except share data and par value)
| Year Ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $37,568 | $28,670 |
| Short-term investments | 108,129 | 18,567 |
| Accounts receivable, net | — | 5,903 |
| Inventory | — | 5,311 |
| Prepaid expenses and other current assets | 3,316 | 2,836 |
| Total current assets | 149,013 | 61,287 |
| Property and equipment, net | 3 | 6,846 |
| Operating lease right-of-use assets | — | 787 |
| Other assets | 1,814 | 1,399 |
| Total assets | $150,830 | $70,319 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $917 | $2,159 |
| Accrued liabilities | 13,602 | 14,647 |
| Operating lease liabilities, current portion | — | 268 |
| Total current liabilities | 14,519 | 17,074 |
| Operating lease liabilities, net of current portion | — | 565 |
| Other liabilities | — | 202 |
| Total liabilities | 14,519 | 17,841 |
| Commitments and contingencies (Note 13) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding as of December 31, 2025 and 2024 | — | — |
| Common stock, $0.0001 par value, 300,000,000 shares authorized; 47,145,719 and 24,680,708 shares issued and outstanding as of December 31, 2025 and 2024 respectively | 4 | 2 |
| Additional paid-in capital | 489,437 | 385,114 |
| Accumulated other comprehensive income | 120 | 16 |
| Accumulated deficit | (353,250) | (332,654) |
| Total stockholders’ equity | 136,311 | 52,478 |
| Total liabilities and stockholders’ equity | $150,830 | $70,319 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.